BBMRI-NL2.0 awarded €9.8 million
BBMRI-NL2.0: building on the Dutch biobank
On Tuesday 1 July, BBMRI-NL2.0 was awarded €9.8 million as part of the National Roadmap of Large Research Infrastructures. It is one of the six facilities receiving a grant from NWO. The cheque was handed over during a ceremony at the Leiden University Medical Centre. Professor Cisca Wijmenga (UMCG) is director of this large-scale biobanking project.
BBMRI-NL joins forces with EPI2 and CTMM-TraIT in July 2014, BBMRI-NL embarks upon its second phase: BBMRI-NL2.0
The new endeavour comprises BBMRI-NL and all the biobanks connected with it, and joins forces with two other Dutch projects that aim to facilitate innovative biomedical research: the European Population Imaging Infrastructure (EPI2) and the Translational Research IT project of the Center for Translational Molecular Medicine (CTMM-TraIT). The goal: a truly nationally integrated ‘NL Biobank Research Facility’, offering fully integrated access for research on how genetic and environmental factors contribute to disease. The Netherlands Organisation for Scientific Research, NWO, has awarded BBMRI-NL2.0 a grant of just over €9.8M as part of the National Roadmap of Large Research Infrastructures.
| Last modified: | 18 December 2023 08.30 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.